Long-Term Management of Atopic Dermatitis: The Role of Tralokinumab
Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.